{"transactions":[{"id":424932,"issuer":{"id":2314,"kind":"organization","name":"ABBOTT LABORATORIES","symbol":"ABT"},"owners":[{"id":16171,"kind":"person","name":"ROUSSEAU MICHAEL T","position":1,"cik":"0001233677","reported_name":"ROUSSEAU MICHAEL T","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Pres., Cardiovas. & Neuromod."}}],"security":"Common shares without par value","published_at":"2017-07-11T21:04:06.000Z","date":"2017-07-07","kind":"tax_withholding","acquired":false,"shares":3288,"price":48.44,"value":159270.72,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Due to an administrative calculation error, the Form 4 filed on January 6, 2017, underreported the reporting person's ownership by 1 share."}],"balance_after":183116,"source":{"system":"sec-edgar","filing":"0001179110-17-010300","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1800/000117911017010300/edgar.xml","form_type":"4"}},{"id":431981,"issuer":{"id":2314,"kind":"organization","name":"ABBOTT LABORATORIES","symbol":"ABT"},"owners":[{"id":16171,"kind":"person","name":"ROUSSEAU MICHAEL T","position":1,"cik":"0001233677","reported_name":"ROUSSEAU MICHAEL T","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Pres., Cardiovasc. & Neuromod."}}],"security":"Option (right to buy)","published_at":"2017-01-06T22:29:12.000Z","date":"2017-01-04","kind":"grant","acquired":true,"shares":545573,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F6","text":"Pursuant to terms of the Merger Agreement, at the First Effective Time, each unvested St. Jude Medical stock option was canceled and converted into an option to acquire, on substantially the same terms and conditions (except that, subject to the holder's continued employment, the option will fully vest to the extent unvested on the second anniversary of the First Effective Time), a number of Abbott common shares equal to the product (rounded down to the nearest whole share) of (a) the number of St. Jude Medical common shares subject to such option multiplied by (b) the Stock Award Exchange Ratio, at an exercise price per Abbott common share equal to the quotient (rounded up to the nearest whole cent) of (i) the per share exercise price for the St. Jude Medical common shares subject to such assumed option as of immediately prior to the First Effective Time divided by (ii) the Stock Award Exchange Ratio."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"Pursuant to terms of the Merger Agreement, at the First Effective Time, each unvested St. Jude Medical stock option was canceled and converted into an option to acquire, on substantially the same terms and conditions (except that, subject to the holder's continued employment, the option will fully vest to the extent unvested on the second anniversary of the First Effective Time), a number of Abbott common shares equal to the product (rounded down to the nearest whole share) of (a) the number of St. Jude Medical common shares subject to such option multiplied by (b) the Stock Award Exchange Ratio, at an exercise price per Abbott common share equal to the quotient (rounded up to the nearest whole cent) of (i) the per share exercise price for the St. Jude Medical common shares subject to such assumed option as of immediately prior to the First Effective Time divided by (ii) the Stock Award Exchange Ratio."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F9","text":"181,857 options are scheduled to vest on December 17, 2017, 181,857 options are scheduled to vest on December 17, 2018 and 181,859 options are scheduled to vest on January 4, 2019."}],"balance_after":545573,"derivative":{"exercise_price":29.56,"expiration_date":"2023-12-07","underlying":"Common shares without par value","underlying_shares":545573},"source":{"system":"sec-edgar","filing":"0001104659-17-001247","document":"a4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1800/000110465917001247/a4.xml","form_type":"4"}},{"id":431980,"issuer":{"id":2314,"kind":"organization","name":"ABBOTT LABORATORIES","symbol":"ABT"},"owners":[{"id":16171,"kind":"person","name":"ROUSSEAU MICHAEL T","position":1,"cik":"0001233677","reported_name":"ROUSSEAU MICHAEL T","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Pres., Cardiovasc. & Neuromod."}}],"security":"Option (right to buy)","published_at":"2017-01-06T22:29:12.000Z","date":"2017-01-04","kind":"grant","acquired":true,"shares":150737,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F6","text":"Pursuant to terms of the Merger Agreement, at the First Effective Time, each unvested St. Jude Medical stock option was canceled and converted into an option to acquire, on substantially the same terms and conditions (except that, subject to the holder's continued employment, the option will fully vest to the extent unvested on the second anniversary of the First Effective Time), a number of Abbott common shares equal to the product (rounded down to the nearest whole share) of (a) the number of St. Jude Medical common shares subject to such option multiplied by (b) the Stock Award Exchange Ratio, at an exercise price per Abbott common share equal to the quotient (rounded up to the nearest whole cent) of (i) the per share exercise price for the St. Jude Medical common shares subject to such assumed option as of immediately prior to the First Effective Time divided by (ii) the Stock Award Exchange Ratio."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"Pursuant to terms of the Merger Agreement, at the First Effective Time, each unvested St. Jude Medical stock option was canceled and converted into an option to acquire, on substantially the same terms and conditions (except that, subject to the holder's continued employment, the option will fully vest to the extent unvested on the second anniversary of the First Effective Time), a number of Abbott common shares equal to the product (rounded down to the nearest whole share) of (a) the number of St. Jude Medical common shares subject to such option multiplied by (b) the Stock Award Exchange Ratio, at an exercise price per Abbott common share equal to the quotient (rounded up to the nearest whole cent) of (i) the per share exercise price for the St. Jude Medical common shares subject to such assumed option as of immediately prior to the First Effective Time divided by (ii) the Stock Award Exchange Ratio."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F8","text":"75,368 options are scheduled to vest on December 17, 2017 and 75,369 options are scheduled to vest on December 17, 2018."}],"balance_after":150737,"derivative":{"exercise_price":33.14,"expiration_date":"2022-12-08","underlying":"Common shares without par value","underlying_shares":150737},"source":{"system":"sec-edgar","filing":"0001104659-17-001247","document":"a4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1800/000110465917001247/a4.xml","form_type":"4"}},{"id":431979,"issuer":{"id":2314,"kind":"organization","name":"ABBOTT LABORATORIES","symbol":"ABT"},"owners":[{"id":16171,"kind":"person","name":"ROUSSEAU MICHAEL T","position":1,"cik":"0001233677","reported_name":"ROUSSEAU MICHAEL T","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Pres., Cardiovasc. & Neuromod."}}],"security":"Option (right to buy)","published_at":"2017-01-06T22:29:12.000Z","date":"2017-01-04","kind":"grant","acquired":true,"shares":77739,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F6","text":"Pursuant to terms of the Merger Agreement, at the First Effective Time, each unvested St. Jude Medical stock option was canceled and converted into an option to acquire, on substantially the same terms and conditions (except that, subject to the holder's continued employment, the option will fully vest to the extent unvested on the second anniversary of the First Effective Time), a number of Abbott common shares equal to the product (rounded down to the nearest whole share) of (a) the number of St. Jude Medical common shares subject to such option multiplied by (b) the Stock Award Exchange Ratio, at an exercise price per Abbott common share equal to the quotient (rounded up to the nearest whole cent) of (i) the per share exercise price for the St. Jude Medical common shares subject to such assumed option as of immediately prior to the First Effective Time divided by (ii) the Stock Award Exchange Ratio."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"Pursuant to terms of the Merger Agreement, at the First Effective Time, each unvested St. Jude Medical stock option was canceled and converted into an option to acquire, on substantially the same terms and conditions (except that, subject to the holder's continued employment, the option will fully vest to the extent unvested on the second anniversary of the First Effective Time), a number of Abbott common shares equal to the product (rounded down to the nearest whole share) of (a) the number of St. Jude Medical common shares subject to such option multiplied by (b) the Stock Award Exchange Ratio, at an exercise price per Abbott common share equal to the quotient (rounded up to the nearest whole cent) of (i) the per share exercise price for the St. Jude Medical common shares subject to such assumed option as of immediately prior to the First Effective Time divided by (ii) the Stock Award Exchange Ratio."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F7","text":"These options are scheduled to vest on December 17, 2017."}],"balance_after":77739,"derivative":{"exercise_price":28.5,"expiration_date":"2021-12-10","underlying":"Common shares without par value","underlying_shares":77739},"source":{"system":"sec-edgar","filing":"0001104659-17-001247","document":"a4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1800/000110465917001247/a4.xml","form_type":"4"}},{"id":431978,"issuer":{"id":2314,"kind":"organization","name":"ABBOTT LABORATORIES","symbol":"ABT"},"owners":[{"id":16171,"kind":"person","name":"ROUSSEAU MICHAEL T","position":1,"cik":"0001233677","reported_name":"ROUSSEAU MICHAEL T","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Pres., Cardiovasc. & Neuromod."}}],"security":"Common shares without par value","published_at":"2017-01-06T22:29:12.000Z","date":"2017-01-04","kind":"grant","acquired":true,"shares":429095,"ownership":{"direct":false,"nature":"Family Trust"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Pursuant to terms of the Merger Agreement, at the First Effective Time, each vested St. Jude Medical stock option was deemed exercised pursuant to a cashless exercise and deemed settled by issuance of a number of St. Jude Medical shares equal to the difference (rounded down to the nearest whole share, but with any partial shares otherwise issuable settled in cash) of (a) the number of St. Jude Medical common shares subject to such surrendered St. Jude Medical option as of immediately prior to the First Effective Time minus (b) the number of whole and partial (computed to the nearest four decimal places) St. Jude Medical common shares that, when multiplied by $80.82 (the closing price of a St. Jude Medical common share on January 4, 2017), is equal to the aggregate exercise price of such surrendered St. Jude Medical option. (Continued in footnote 3)."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Such St. Jude Medical common shares were then canceled and converted into the right to receive the merger consideration with respect to each St. Jude Medical common share issued in respect of the stock option, less any applicable withholding taxes."}],"balance_after":632581,"source":{"system":"sec-edgar","filing":"0001104659-17-001247","document":"a4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1800/000110465917001247/a4.xml","form_type":"4"}},{"id":431977,"issuer":{"id":2314,"kind":"organization","name":"ABBOTT LABORATORIES","symbol":"ABT"},"owners":[{"id":16171,"kind":"person","name":"ROUSSEAU MICHAEL T","position":1,"cik":"0001233677","reported_name":"ROUSSEAU MICHAEL T","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Pres., Cardiovasc. & Neuromod."}}],"security":"Common shares without par value","published_at":"2017-01-06T22:29:12.000Z","date":"2017-01-04","kind":"grant","acquired":true,"shares":17083,"ownership":{"direct":false,"nature":"Family Trust"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"On January 4, 2017, Abbott Laboratories (\"Abbott\") acquired St. Jude Medical, Inc. (\"St. Jude Medical\") pursuant to the Agreement and Plan of Merger by and among Abbott, St. Jude Medical, Vault Merger Sub, Inc. and Vault Merger Sub, LLC dated as of April 27, 2016 (the \"Merger Agreement\").  Upon the First Effective Time (as defined in the Merger Agreement), each outstanding St. Jude Medical common share (other than certain shares identified in the Merger Agreement) was converted into the right to receive (a) $46.75 in cash, without interest, and (b) 0.8708 common shares of Abbott."}],"balance_after":203486,"source":{"system":"sec-edgar","filing":"0001104659-17-001247","document":"a4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1800/000110465917001247/a4.xml","form_type":"4"}},{"id":431976,"issuer":{"id":2314,"kind":"organization","name":"ABBOTT LABORATORIES","symbol":"ABT"},"owners":[{"id":16171,"kind":"person","name":"ROUSSEAU MICHAEL T","position":1,"cik":"0001233677","reported_name":"ROUSSEAU MICHAEL T","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Pres., Cardiovasc. & Neuromod."}}],"security":"Common shares without par value","published_at":"2017-01-06T22:29:12.000Z","date":"2017-01-04","kind":"grant","acquired":true,"shares":84394,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F4","text":"Pursuant to terms of the Merger Agreement, at the First Effective Time, each unvested St. Jude Medical restricted stock unit award was canceled and converted into a restricted stock unit award, with substantially the same terms and conditions as were applicable to such St. Jude Medical award (except that, subject to the holder's continued employment, the award will fully vest to the extent unvested on the second anniversary of the First Effective Time), that is settleable with respect to a number of Abbott common shares equal to the product (rounded to the nearest whole share) of (a) the number of St. Jude Medical shares subject to such award multiplied by (b)  2.0850 (the \"Stock Award Exchange Ratio\")."},{"field":"shares","element":"transactionShares","label":"F5","text":"37,204 restricted stock units are scheduled to vest on December 17, 2017 and will be settled promptly thereafter, 27,876 restricted stock units are scheduled to vest on December 17, 2018 and will be settled promptly thereafter, and 19,314 restricted stock units are scheduled to vest on January 4, 2019 and will be settled December 17, 2019."}],"balance_after":186403,"source":{"system":"sec-edgar","filing":"0001104659-17-001247","document":"a4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1800/000110465917001247/a4.xml","form_type":"4"}},{"id":431975,"issuer":{"id":2314,"kind":"organization","name":"ABBOTT LABORATORIES","symbol":"ABT"},"owners":[{"id":16171,"kind":"person","name":"ROUSSEAU MICHAEL T","position":1,"cik":"0001233677","reported_name":"ROUSSEAU MICHAEL T","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Pres., Cardiovasc. & Neuromod."}}],"security":"Common shares without par value","published_at":"2017-01-06T22:29:12.000Z","date":"2017-01-04","kind":"grant","acquired":true,"shares":61275,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Pursuant to terms of the Merger Agreement, at the First Effective Time, each vested St. Jude Medical stock option was deemed exercised pursuant to a cashless exercise and deemed settled by issuance of a number of St. Jude Medical shares equal to the difference (rounded down to the nearest whole share, but with any partial shares otherwise issuable settled in cash) of (a) the number of St. Jude Medical common shares subject to such surrendered St. Jude Medical option as of immediately prior to the First Effective Time minus (b) the number of whole and partial (computed to the nearest four decimal places) St. Jude Medical common shares that, when multiplied by $80.82 (the closing price of a St. Jude Medical common share on January 4, 2017), is equal to the aggregate exercise price of such surrendered St. Jude Medical option. (Continued in footnote 3)."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Such St. Jude Medical common shares were then canceled and converted into the right to receive the merger consideration with respect to each St. Jude Medical common share issued in respect of the stock option, less any applicable withholding taxes."}],"balance_after":102010,"source":{"system":"sec-edgar","filing":"0001104659-17-001247","document":"a4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1800/000110465917001247/a4.xml","form_type":"4"}},{"id":431974,"issuer":{"id":2314,"kind":"organization","name":"ABBOTT LABORATORIES","symbol":"ABT"},"owners":[{"id":16171,"kind":"person","name":"ROUSSEAU MICHAEL T","position":1,"cik":"0001233677","reported_name":"ROUSSEAU MICHAEL T","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Pres., Cardiovasc. & Neuromod."}}],"security":"Common shares without par value","published_at":"2017-01-06T22:29:12.000Z","date":"2017-01-04","kind":"grant","acquired":true,"shares":40735,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"On January 4, 2017, Abbott Laboratories (\"Abbott\") acquired St. Jude Medical, Inc. (\"St. Jude Medical\") pursuant to the Agreement and Plan of Merger by and among Abbott, St. Jude Medical, Vault Merger Sub, Inc. and Vault Merger Sub, LLC dated as of April 27, 2016 (the \"Merger Agreement\").  Upon the First Effective Time (as defined in the Merger Agreement), each outstanding St. Jude Medical common share (other than certain shares identified in the Merger Agreement) was converted into the right to receive (a) $46.75 in cash, without interest, and (b) 0.8708 common shares of Abbott."}],"balance_after":40735,"source":{"system":"sec-edgar","filing":"0001104659-17-001247","document":"a4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1800/000110465917001247/a4.xml","form_type":"4"}},{"id":4497418,"issuer":{"id":179857,"kind":"organization","name":"ST JUDE MEDICAL, LLC","symbol":"STJ"},"owners":[{"id":16171,"kind":"person","name":"ROUSSEAU MICHAEL T","position":1,"cik":"0001233677","reported_name":"ROUSSEAU MICHAEL T","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Director, President and CEO"}}],"security":"Restricted Stock Units","published_at":"2017-01-06T13:56:25.000Z","date":"2017-01-04","kind":"disposition_to_issuer","acquired":false,"shares":27789,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F4","text":"Pursuant to the Merger Agreement, each unvested restricted stock unit was assumed by Abbott and converted into restricted stock units for the number of shares of Abbott Common Stock equal to the product (rounded to the nearest whole share) of (i) the number of shares of Issuer Common Stock subject to such restricted stock unit immediately prior to the Mergers multiplied by (ii) the Stock Award Exchange Ratio."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"Pursuant to the Merger Agreement, each unvested restricted stock unit was assumed by Abbott and converted into restricted stock units for the number of shares of Abbott Common Stock equal to the product (rounded to the nearest whole share) of (i) the number of shares of Issuer Common Stock subject to such restricted stock unit immediately prior to the Mergers multiplied by (ii) the Stock Award Exchange Ratio."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Pursuant to the Merger Agreement, each unvested restricted stock unit was assumed by Abbott and converted into restricted stock units for the number of shares of Abbott Common Stock equal to the product (rounded to the nearest whole share) of (i) the number of shares of Issuer Common Stock subject to such restricted stock unit immediately prior to the Mergers multiplied by (ii) the Stock Award Exchange Ratio."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"Pursuant to the Merger Agreement, each unvested restricted stock unit was assumed by Abbott and converted into restricted stock units for the number of shares of Abbott Common Stock equal to the product (rounded to the nearest whole share) of (i) the number of shares of Issuer Common Stock subject to such restricted stock unit immediately prior to the Mergers multiplied by (ii) the Stock Award Exchange Ratio."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":27789},"source":{"system":"sec-edgar","filing":"0001179110-17-000618","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":15,"url":"https://www.sec.gov/Archives/edgar/data/203077/000117911017000618/edgar.xml","form_type":"4"}},{"id":4497417,"issuer":{"id":179857,"kind":"organization","name":"ST JUDE MEDICAL, LLC","symbol":"STJ"},"owners":[{"id":16171,"kind":"person","name":"ROUSSEAU MICHAEL T","position":1,"cik":"0001233677","reported_name":"ROUSSEAU MICHAEL T","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Director, President and CEO"}}],"security":"Stock Options (Right to Buy)","published_at":"2017-01-06T13:56:25.000Z","date":"2017-01-04","kind":"disposition_to_issuer","acquired":false,"shares":348888,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Each option provided for vesting in four equal installments on December 17 commencing one year after the date shown in the table.  Pursuant to the Merger Agreement, the vested options were treated as set forth in note (2).  The unvested options were assumed by Abbott and converted into an option to acquire the number of shares of Abbott Common Stock equal to the product (rounded down to the nearest whole share) of (i) the number of shares of Issuer Common Stock subject to such option immediately prior to the Mergers multiplied by (ii) the Stock Award Exchange Ratio (as defined in the Merger Agreement), at an exercise price per share of Abbott stock equal to the quotient (rounded up to the nearest whole cent) of (A) the per share exercise price for the shares of Issuer Common Stock subject to such option immediately prior to the Mergers divided by (B) the Stock Award Exchange Ratio."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Each option provided for vesting in four equal installments on December 17 commencing one year after the date shown in the table.  Pursuant to the Merger Agreement, the vested options were treated as set forth in note (2).  The unvested options were assumed by Abbott and converted into an option to acquire the number of shares of Abbott Common Stock equal to the product (rounded down to the nearest whole share) of (i) the number of shares of Issuer Common Stock subject to such option immediately prior to the Mergers multiplied by (ii) the Stock Award Exchange Ratio (as defined in the Merger Agreement), at an exercise price per share of Abbott stock equal to the quotient (rounded up to the nearest whole cent) of (A) the per share exercise price for the shares of Issuer Common Stock subject to such option immediately prior to the Mergers divided by (B) the Stock Award Exchange Ratio."}],"balance_after":0,"derivative":{"exercise_price":61.62,"exercise_date":"2016-12-17","expiration_date":"2023-12-07","underlying":"Common Stock","underlying_shares":348888},"source":{"system":"sec-edgar","filing":"0001179110-17-000618","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":14,"url":"https://www.sec.gov/Archives/edgar/data/203077/000117911017000618/edgar.xml","form_type":"4"}},{"id":4497416,"issuer":{"id":179857,"kind":"organization","name":"ST JUDE MEDICAL, LLC","symbol":"STJ"},"owners":[{"id":16171,"kind":"person","name":"ROUSSEAU MICHAEL T","position":1,"cik":"0001233677","reported_name":"ROUSSEAU MICHAEL T","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Director, President and CEO"}}],"security":"Restricted Stock Units","published_at":"2017-01-06T13:56:25.000Z","date":"2017-01-04","kind":"disposition_to_issuer","acquired":false,"shares":8214,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F4","text":"Pursuant to the Merger Agreement, each unvested restricted stock unit was assumed by Abbott and converted into restricted stock units for the number of shares of Abbott Common Stock equal to the product (rounded to the nearest whole share) of (i) the number of shares of Issuer Common Stock subject to such restricted stock unit immediately prior to the Mergers multiplied by (ii) the Stock Award Exchange Ratio."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"Pursuant to the Merger Agreement, each unvested restricted stock unit was assumed by Abbott and converted into restricted stock units for the number of shares of Abbott Common Stock equal to the product (rounded to the nearest whole share) of (i) the number of shares of Issuer Common Stock subject to such restricted stock unit immediately prior to the Mergers multiplied by (ii) the Stock Award Exchange Ratio."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Pursuant to the Merger Agreement, each unvested restricted stock unit was assumed by Abbott and converted into restricted stock units for the number of shares of Abbott Common Stock equal to the product (rounded to the nearest whole share) of (i) the number of shares of Issuer Common Stock subject to such restricted stock unit immediately prior to the Mergers multiplied by (ii) the Stock Award Exchange Ratio."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"Pursuant to the Merger Agreement, each unvested restricted stock unit was assumed by Abbott and converted into restricted stock units for the number of shares of Abbott Common Stock equal to the product (rounded to the nearest whole share) of (i) the number of shares of Issuer Common Stock subject to such restricted stock unit immediately prior to the Mergers multiplied by (ii) the Stock Award Exchange Ratio."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":8214},"source":{"system":"sec-edgar","filing":"0001179110-17-000618","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":13,"url":"https://www.sec.gov/Archives/edgar/data/203077/000117911017000618/edgar.xml","form_type":"4"}},{"id":4497415,"issuer":{"id":179857,"kind":"organization","name":"ST JUDE MEDICAL, LLC","symbol":"STJ"},"owners":[{"id":16171,"kind":"person","name":"ROUSSEAU MICHAEL T","position":1,"cik":"0001233677","reported_name":"ROUSSEAU MICHAEL T","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Director, President and CEO"}}],"security":"Stock Options (Right to Buy)","published_at":"2017-01-06T13:56:25.000Z","date":"2017-01-04","kind":"disposition_to_issuer","acquired":false,"shares":36148,"ownership":{"direct":false,"nature":"Family Trust"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Pursuant to the terms of the Merger Agreement, each option that was fully vested and exercisable immediately prior to the Mergers was deemed exercised pursuant to a cashless exercise and settled by issuance of a number of shares of Issuer Common Stock (\"Net Exercise Shares\") equal to the excess (rounded down to the nearest whole share, but with any partial shares otherwise issuable settled in cash) of (i) the number of Issuer shares of Common Stock subject to such option immediately prior to the Mergers over (ii) the number of whole and partial (computed to the nearest four decimal places) Issuer shares of Common Stock that, when multiplied by the Company equity plan-defined FMV, is equal to the aggregate exercise price of the exercised options.  Each Net Exercise Share was then canceled and converted into the right to receive the Merger Consideration, less any applicable withholding taxes."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Pursuant to the terms of the Merger Agreement, each option that was fully vested and exercisable immediately prior to the Mergers was deemed exercised pursuant to a cashless exercise and settled by issuance of a number of shares of Issuer Common Stock (\"Net Exercise Shares\") equal to the excess (rounded down to the nearest whole share, but with any partial shares otherwise issuable settled in cash) of (i) the number of Issuer shares of Common Stock subject to such option immediately prior to the Mergers over (ii) the number of whole and partial (computed to the nearest four decimal places) Issuer shares of Common Stock that, when multiplied by the Company equity plan-defined FMV, is equal to the aggregate exercise price of the exercised options.  Each Net Exercise Share was then canceled and converted into the right to receive the Merger Consideration, less any applicable withholding taxes."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F5","text":"The reporting person disclaims beneficial ownership of these securities, and this report shall not be deemed an admission that the reporting person is the beneficial owner of the securities for purposes of Section 16 or for any other purpose."}],"balance_after":0,"derivative":{"exercise_price":69.08,"exercise_date":"2015-12-17","expiration_date":"2022-12-08","underlying":"Common Stock","underlying_shares":36148},"source":{"system":"sec-edgar","filing":"0001179110-17-000618","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":12,"url":"https://www.sec.gov/Archives/edgar/data/203077/000117911017000618/edgar.xml","form_type":"4"}},{"id":4497414,"issuer":{"id":179857,"kind":"organization","name":"ST JUDE MEDICAL, LLC","symbol":"STJ"},"owners":[{"id":16171,"kind":"person","name":"ROUSSEAU MICHAEL T","position":1,"cik":"0001233677","reported_name":"ROUSSEAU MICHAEL T","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Director, President and CEO"}}],"security":"Stock Options (Right to Buy)","published_at":"2017-01-06T13:56:25.000Z","date":"2017-01-04","kind":"disposition_to_issuer","acquired":false,"shares":108444,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Each option provided for vesting in four equal installments on December 17 commencing one year after the date shown in the table.  Pursuant to the Merger Agreement, the vested options were treated as set forth in note (2).  The unvested options were assumed by Abbott and converted into an option to acquire the number of shares of Abbott Common Stock equal to the product (rounded down to the nearest whole share) of (i) the number of shares of Issuer Common Stock subject to such option immediately prior to the Mergers multiplied by (ii) the Stock Award Exchange Ratio (as defined in the Merger Agreement), at an exercise price per share of Abbott stock equal to the quotient (rounded up to the nearest whole cent) of (A) the per share exercise price for the shares of Issuer Common Stock subject to such option immediately prior to the Mergers divided by (B) the Stock Award Exchange Ratio."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Each option provided for vesting in four equal installments on December 17 commencing one year after the date shown in the table.  Pursuant to the Merger Agreement, the vested options were treated as set forth in note (2).  The unvested options were assumed by Abbott and converted into an option to acquire the number of shares of Abbott Common Stock equal to the product (rounded down to the nearest whole share) of (i) the number of shares of Issuer Common Stock subject to such option immediately prior to the Mergers multiplied by (ii) the Stock Award Exchange Ratio (as defined in the Merger Agreement), at an exercise price per share of Abbott stock equal to the quotient (rounded up to the nearest whole cent) of (A) the per share exercise price for the shares of Issuer Common Stock subject to such option immediately prior to the Mergers divided by (B) the Stock Award Exchange Ratio."}],"balance_after":0,"derivative":{"exercise_price":69.08,"exercise_date":"2015-12-17","expiration_date":"2016-12-08","underlying":"Common Stock","underlying_shares":108444},"source":{"system":"sec-edgar","filing":"0001179110-17-000618","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":11,"url":"https://www.sec.gov/Archives/edgar/data/203077/000117911017000618/edgar.xml","form_type":"4"}},{"id":4497413,"issuer":{"id":179857,"kind":"organization","name":"ST JUDE MEDICAL, LLC","symbol":"STJ"},"owners":[{"id":16171,"kind":"person","name":"ROUSSEAU MICHAEL T","position":1,"cik":"0001233677","reported_name":"ROUSSEAU MICHAEL T","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Director, President and CEO"}}],"security":"Restricted Stock Units","published_at":"2017-01-06T13:56:25.000Z","date":"2017-01-04","kind":"disposition_to_issuer","acquired":false,"shares":4474,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F4","text":"Pursuant to the Merger Agreement, each unvested restricted stock unit was assumed by Abbott and converted into restricted stock units for the number of shares of Abbott Common Stock equal to the product (rounded to the nearest whole share) of (i) the number of shares of Issuer Common Stock subject to such restricted stock unit immediately prior to the Mergers multiplied by (ii) the Stock Award Exchange Ratio."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"Pursuant to the Merger Agreement, each unvested restricted stock unit was assumed by Abbott and converted into restricted stock units for the number of shares of Abbott Common Stock equal to the product (rounded to the nearest whole share) of (i) the number of shares of Issuer Common Stock subject to such restricted stock unit immediately prior to the Mergers multiplied by (ii) the Stock Award Exchange Ratio."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Pursuant to the Merger Agreement, each unvested restricted stock unit was assumed by Abbott and converted into restricted stock units for the number of shares of Abbott Common Stock equal to the product (rounded to the nearest whole share) of (i) the number of shares of Issuer Common Stock subject to such restricted stock unit immediately prior to the Mergers multiplied by (ii) the Stock Award Exchange Ratio."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"Pursuant to the Merger Agreement, each unvested restricted stock unit was assumed by Abbott and converted into restricted stock units for the number of shares of Abbott Common Stock equal to the product (rounded to the nearest whole share) of (i) the number of shares of Issuer Common Stock subject to such restricted stock unit immediately prior to the Mergers multiplied by (ii) the Stock Award Exchange Ratio."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":4474},"source":{"system":"sec-edgar","filing":"0001179110-17-000618","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":10,"url":"https://www.sec.gov/Archives/edgar/data/203077/000117911017000618/edgar.xml","form_type":"4"}},{"id":4497412,"issuer":{"id":179857,"kind":"organization","name":"ST JUDE MEDICAL, LLC","symbol":"STJ"},"owners":[{"id":16171,"kind":"person","name":"ROUSSEAU MICHAEL T","position":1,"cik":"0001233677","reported_name":"ROUSSEAU MICHAEL T","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Director, President and CEO"}}],"security":"Stock Options (Right to Buy)","published_at":"2017-01-06T13:56:25.000Z","date":"2017-01-04","kind":"disposition_to_issuer","acquired":false,"shares":74570,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Each option provided for vesting in four equal installments on December 17 commencing one year after the date shown in the table.  Pursuant to the Merger Agreement, the vested options were treated as set forth in note (2).  The unvested options were assumed by Abbott and converted into an option to acquire the number of shares of Abbott Common Stock equal to the product (rounded down to the nearest whole share) of (i) the number of shares of Issuer Common Stock subject to such option immediately prior to the Mergers multiplied by (ii) the Stock Award Exchange Ratio (as defined in the Merger Agreement), at an exercise price per share of Abbott stock equal to the quotient (rounded up to the nearest whole cent) of (A) the per share exercise price for the shares of Issuer Common Stock subject to such option immediately prior to the Mergers divided by (B) the Stock Award Exchange Ratio."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Each option provided for vesting in four equal installments on December 17 commencing one year after the date shown in the table.  Pursuant to the Merger Agreement, the vested options were treated as set forth in note (2).  The unvested options were assumed by Abbott and converted into an option to acquire the number of shares of Abbott Common Stock equal to the product (rounded down to the nearest whole share) of (i) the number of shares of Issuer Common Stock subject to such option immediately prior to the Mergers multiplied by (ii) the Stock Award Exchange Ratio (as defined in the Merger Agreement), at an exercise price per share of Abbott stock equal to the quotient (rounded up to the nearest whole cent) of (A) the per share exercise price for the shares of Issuer Common Stock subject to such option immediately prior to the Mergers divided by (B) the Stock Award Exchange Ratio."}],"balance_after":0,"derivative":{"exercise_price":59.41,"exercise_date":"2014-12-17","expiration_date":"2021-12-10","underlying":"Common Stock","underlying_shares":74570},"source":{"system":"sec-edgar","filing":"0001179110-17-000618","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/203077/000117911017000618/edgar.xml","form_type":"4"}},{"id":4497411,"issuer":{"id":179857,"kind":"organization","name":"ST JUDE MEDICAL, LLC","symbol":"STJ"},"owners":[{"id":16171,"kind":"person","name":"ROUSSEAU MICHAEL T","position":1,"cik":"0001233677","reported_name":"ROUSSEAU MICHAEL T","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Director, President and CEO"}}],"security":"Stock Options (Right to Buy)","published_at":"2017-01-06T13:56:25.000Z","date":"2017-01-04","kind":"disposition_to_issuer","acquired":false,"shares":74570,"ownership":{"direct":false,"nature":"Family Trust"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Pursuant to the terms of the Merger Agreement, each option that was fully vested and exercisable immediately prior to the Mergers was deemed exercised pursuant to a cashless exercise and settled by issuance of a number of shares of Issuer Common Stock (\"Net Exercise Shares\") equal to the excess (rounded down to the nearest whole share, but with any partial shares otherwise issuable settled in cash) of (i) the number of Issuer shares of Common Stock subject to such option immediately prior to the Mergers over (ii) the number of whole and partial (computed to the nearest four decimal places) Issuer shares of Common Stock that, when multiplied by the Company equity plan-defined FMV, is equal to the aggregate exercise price of the exercised options.  Each Net Exercise Share was then canceled and converted into the right to receive the Merger Consideration, less any applicable withholding taxes."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Pursuant to the terms of the Merger Agreement, each option that was fully vested and exercisable immediately prior to the Mergers was deemed exercised pursuant to a cashless exercise and settled by issuance of a number of shares of Issuer Common Stock (\"Net Exercise Shares\") equal to the excess (rounded down to the nearest whole share, but with any partial shares otherwise issuable settled in cash) of (i) the number of Issuer shares of Common Stock subject to such option immediately prior to the Mergers over (ii) the number of whole and partial (computed to the nearest four decimal places) Issuer shares of Common Stock that, when multiplied by the Company equity plan-defined FMV, is equal to the aggregate exercise price of the exercised options.  Each Net Exercise Share was then canceled and converted into the right to receive the Merger Consideration, less any applicable withholding taxes."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F5","text":"The reporting person disclaims beneficial ownership of these securities, and this report shall not be deemed an admission that the reporting person is the beneficial owner of the securities for purposes of Section 16 or for any other purpose."}],"balance_after":0,"derivative":{"exercise_price":59.41,"exercise_date":"2014-12-17","expiration_date":"2021-12-10","underlying":"Common Stock","underlying_shares":74570},"source":{"system":"sec-edgar","filing":"0001179110-17-000618","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/203077/000117911017000618/edgar.xml","form_type":"4"}},{"id":4497410,"issuer":{"id":179857,"kind":"organization","name":"ST JUDE MEDICAL, LLC","symbol":"STJ"},"owners":[{"id":16171,"kind":"person","name":"ROUSSEAU MICHAEL T","position":1,"cik":"0001233677","reported_name":"ROUSSEAU MICHAEL T","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Director, President and CEO"}}],"security":"Stock Options (Right to Buy)","published_at":"2017-01-06T13:56:25.000Z","date":"2017-01-04","kind":"disposition_to_issuer","acquired":false,"shares":61250,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Pursuant to the terms of the Merger Agreement, each option that was fully vested and exercisable immediately prior to the Mergers was deemed exercised pursuant to a cashless exercise and settled by issuance of a number of shares of Issuer Common Stock (\"Net Exercise Shares\") equal to the excess (rounded down to the nearest whole share, but with any partial shares otherwise issuable settled in cash) of (i) the number of Issuer shares of Common Stock subject to such option immediately prior to the Mergers over (ii) the number of whole and partial (computed to the nearest four decimal places) Issuer shares of Common Stock that, when multiplied by the Company equity plan-defined FMV, is equal to the aggregate exercise price of the exercised options.  Each Net Exercise Share was then canceled and converted into the right to receive the Merger Consideration, less any applicable withholding taxes."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Pursuant to the terms of the Merger Agreement, each option that was fully vested and exercisable immediately prior to the Mergers was deemed exercised pursuant to a cashless exercise and settled by issuance of a number of shares of Issuer Common Stock (\"Net Exercise Shares\") equal to the excess (rounded down to the nearest whole share, but with any partial shares otherwise issuable settled in cash) of (i) the number of Issuer shares of Common Stock subject to such option immediately prior to the Mergers over (ii) the number of whole and partial (computed to the nearest four decimal places) Issuer shares of Common Stock that, when multiplied by the Company equity plan-defined FMV, is equal to the aggregate exercise price of the exercised options.  Each Net Exercise Share was then canceled and converted into the right to receive the Merger Consideration, less any applicable withholding taxes."}],"balance_after":0,"derivative":{"exercise_price":35.27,"exercise_date":"2013-12-17","expiration_date":"2020-12-10","underlying":"Common Stock","underlying_shares":61250},"source":{"system":"sec-edgar","filing":"0001179110-17-000618","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/203077/000117911017000618/edgar.xml","form_type":"4"}},{"id":4497409,"issuer":{"id":179857,"kind":"organization","name":"ST JUDE MEDICAL, LLC","symbol":"STJ"},"owners":[{"id":16171,"kind":"person","name":"ROUSSEAU MICHAEL T","position":1,"cik":"0001233677","reported_name":"ROUSSEAU MICHAEL T","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Director, President and CEO"}}],"security":"Stock Options (Right to Buy)","published_at":"2017-01-06T13:56:25.000Z","date":"2017-01-04","kind":"disposition_to_issuer","acquired":false,"shares":183750,"ownership":{"direct":false,"nature":"Family Trust"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Pursuant to the terms of the Merger Agreement, each option that was fully vested and exercisable immediately prior to the Mergers was deemed exercised pursuant to a cashless exercise and settled by issuance of a number of shares of Issuer Common Stock (\"Net Exercise Shares\") equal to the excess (rounded down to the nearest whole share, but with any partial shares otherwise issuable settled in cash) of (i) the number of Issuer shares of Common Stock subject to such option immediately prior to the Mergers over (ii) the number of whole and partial (computed to the nearest four decimal places) Issuer shares of Common Stock that, when multiplied by the Company equity plan-defined FMV, is equal to the aggregate exercise price of the exercised options.  Each Net Exercise Share was then canceled and converted into the right to receive the Merger Consideration, less any applicable withholding taxes."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Pursuant to the terms of the Merger Agreement, each option that was fully vested and exercisable immediately prior to the Mergers was deemed exercised pursuant to a cashless exercise and settled by issuance of a number of shares of Issuer Common Stock (\"Net Exercise Shares\") equal to the excess (rounded down to the nearest whole share, but with any partial shares otherwise issuable settled in cash) of (i) the number of Issuer shares of Common Stock subject to such option immediately prior to the Mergers over (ii) the number of whole and partial (computed to the nearest four decimal places) Issuer shares of Common Stock that, when multiplied by the Company equity plan-defined FMV, is equal to the aggregate exercise price of the exercised options.  Each Net Exercise Share was then canceled and converted into the right to receive the Merger Consideration, less any applicable withholding taxes."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F5","text":"The reporting person disclaims beneficial ownership of these securities, and this report shall not be deemed an admission that the reporting person is the beneficial owner of the securities for purposes of Section 16 or for any other purpose."}],"balance_after":0,"derivative":{"exercise_price":35.27,"exercise_date":"2013-12-17","expiration_date":"2020-12-10","underlying":"Common Stock","underlying_shares":183750},"source":{"system":"sec-edgar","filing":"0001179110-17-000618","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/203077/000117911017000618/edgar.xml","form_type":"4"}},{"id":4497408,"issuer":{"id":179857,"kind":"organization","name":"ST JUDE MEDICAL, LLC","symbol":"STJ"},"owners":[{"id":16171,"kind":"person","name":"ROUSSEAU MICHAEL T","position":1,"cik":"0001233677","reported_name":"ROUSSEAU MICHAEL T","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Director, President and CEO"}}],"security":"Stock Options (Right to Buy)","published_at":"2017-01-06T13:56:25.000Z","date":"2017-01-04","kind":"disposition_to_issuer","acquired":false,"shares":300000,"ownership":{"direct":false,"nature":"Family Trust"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Pursuant to the terms of the Merger Agreement, each option that was fully vested and exercisable immediately prior to the Mergers was deemed exercised pursuant to a cashless exercise and settled by issuance of a number of shares of Issuer Common Stock (\"Net Exercise Shares\") equal to the excess (rounded down to the nearest whole share, but with any partial shares otherwise issuable settled in cash) of (i) the number of Issuer shares of Common Stock subject to such option immediately prior to the Mergers over (ii) the number of whole and partial (computed to the nearest four decimal places) Issuer shares of Common Stock that, when multiplied by the Company equity plan-defined FMV, is equal to the aggregate exercise price of the exercised options.  Each Net Exercise Share was then canceled and converted into the right to receive the Merger Consideration, less any applicable withholding taxes."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Pursuant to the terms of the Merger Agreement, each option that was fully vested and exercisable immediately prior to the Mergers was deemed exercised pursuant to a cashless exercise and settled by issuance of a number of shares of Issuer Common Stock (\"Net Exercise Shares\") equal to the excess (rounded down to the nearest whole share, but with any partial shares otherwise issuable settled in cash) of (i) the number of Issuer shares of Common Stock subject to such option immediately prior to the Mergers over (ii) the number of whole and partial (computed to the nearest four decimal places) Issuer shares of Common Stock that, when multiplied by the Company equity plan-defined FMV, is equal to the aggregate exercise price of the exercised options.  Each Net Exercise Share was then canceled and converted into the right to receive the Merger Consideration, less any applicable withholding taxes."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F5","text":"The reporting person disclaims beneficial ownership of these securities, and this report shall not be deemed an admission that the reporting person is the beneficial owner of the securities for purposes of Section 16 or for any other purpose."}],"balance_after":0,"derivative":{"exercise_price":34.96,"exercise_date":"2012-12-17","expiration_date":"2019-12-12","underlying":"Common Stock","underlying_shares":300000},"source":{"system":"sec-edgar","filing":"0001179110-17-000618","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/203077/000117911017000618/edgar.xml","form_type":"4"}},{"id":4497407,"issuer":{"id":179857,"kind":"organization","name":"ST JUDE MEDICAL, LLC","symbol":"STJ"},"owners":[{"id":16171,"kind":"person","name":"ROUSSEAU MICHAEL T","position":1,"cik":"0001233677","reported_name":"ROUSSEAU MICHAEL T","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Director, President and CEO"}}],"security":"Stock Options (Right to Buy)","published_at":"2017-01-06T13:56:25.000Z","date":"2017-01-04","kind":"disposition_to_issuer","acquired":false,"shares":204000,"ownership":{"direct":false,"nature":"Family Trust"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Pursuant to the terms of the Merger Agreement, each option that was fully vested and exercisable immediately prior to the Mergers was deemed exercised pursuant to a cashless exercise and settled by issuance of a number of shares of Issuer Common Stock (\"Net Exercise Shares\") equal to the excess (rounded down to the nearest whole share, but with any partial shares otherwise issuable settled in cash) of (i) the number of Issuer shares of Common Stock subject to such option immediately prior to the Mergers over (ii) the number of whole and partial (computed to the nearest four decimal places) Issuer shares of Common Stock that, when multiplied by the Company equity plan-defined FMV, is equal to the aggregate exercise price of the exercised options.  Each Net Exercise Share was then canceled and converted into the right to receive the Merger Consideration, less any applicable withholding taxes."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Pursuant to the terms of the Merger Agreement, each option that was fully vested and exercisable immediately prior to the Mergers was deemed exercised pursuant to a cashless exercise and settled by issuance of a number of shares of Issuer Common Stock (\"Net Exercise Shares\") equal to the excess (rounded down to the nearest whole share, but with any partial shares otherwise issuable settled in cash) of (i) the number of Issuer shares of Common Stock subject to such option immediately prior to the Mergers over (ii) the number of whole and partial (computed to the nearest four decimal places) Issuer shares of Common Stock that, when multiplied by the Company equity plan-defined FMV, is equal to the aggregate exercise price of the exercised options.  Each Net Exercise Share was then canceled and converted into the right to receive the Merger Consideration, less any applicable withholding taxes."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F5","text":"The reporting person disclaims beneficial ownership of these securities, and this report shall not be deemed an admission that the reporting person is the beneficial owner of the securities for purposes of Section 16 or for any other purpose."}],"balance_after":0,"derivative":{"exercise_price":41.65,"exercise_date":"2011-12-14","expiration_date":"2018-12-14","underlying":"Common Stock","underlying_shares":204000},"source":{"system":"sec-edgar","filing":"0001179110-17-000618","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/203077/000117911017000618/edgar.xml","form_type":"4"}},{"id":4497406,"issuer":{"id":179857,"kind":"organization","name":"ST JUDE MEDICAL, LLC","symbol":"STJ"},"owners":[{"id":16171,"kind":"person","name":"ROUSSEAU MICHAEL T","position":1,"cik":"0001233677","reported_name":"ROUSSEAU MICHAEL T","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Director, President and CEO"}}],"security":"Stock Options (Right to Buy)","published_at":"2017-01-06T13:56:25.000Z","date":"2017-01-04","kind":"disposition_to_issuer","acquired":false,"shares":182000,"ownership":{"direct":false,"nature":"Family Trust"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Pursuant to the terms of the Merger Agreement, each option that was fully vested and exercisable immediately prior to the Mergers was deemed exercised pursuant to a cashless exercise and settled by issuance of a number of shares of Issuer Common Stock (\"Net Exercise Shares\") equal to the excess (rounded down to the nearest whole share, but with any partial shares otherwise issuable settled in cash) of (i) the number of Issuer shares of Common Stock subject to such option immediately prior to the Mergers over (ii) the number of whole and partial (computed to the nearest four decimal places) Issuer shares of Common Stock that, when multiplied by the Company equity plan-defined FMV, is equal to the aggregate exercise price of the exercised options.  Each Net Exercise Share was then canceled and converted into the right to receive the Merger Consideration, less any applicable withholding taxes."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Pursuant to the terms of the Merger Agreement, each option that was fully vested and exercisable immediately prior to the Mergers was deemed exercised pursuant to a cashless exercise and settled by issuance of a number of shares of Issuer Common Stock (\"Net Exercise Shares\") equal to the excess (rounded down to the nearest whole share, but with any partial shares otherwise issuable settled in cash) of (i) the number of Issuer shares of Common Stock subject to such option immediately prior to the Mergers over (ii) the number of whole and partial (computed to the nearest four decimal places) Issuer shares of Common Stock that, when multiplied by the Company equity plan-defined FMV, is equal to the aggregate exercise price of the exercised options.  Each Net Exercise Share was then canceled and converted into the right to receive the Merger Consideration, less any applicable withholding taxes."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F5","text":"The reporting person disclaims beneficial ownership of these securities, and this report shall not be deemed an admission that the reporting person is the beneficial owner of the securities for purposes of Section 16 or for any other purpose."}],"balance_after":0,"derivative":{"exercise_price":38.59,"exercise_date":"2010-12-14","expiration_date":"2017-12-14","underlying":"Common Stock","underlying_shares":182000},"source":{"system":"sec-edgar","filing":"0001179110-17-000618","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/203077/000117911017000618/edgar.xml","form_type":"4"}},{"id":4497405,"issuer":{"id":179857,"kind":"organization","name":"ST JUDE MEDICAL, LLC","symbol":"STJ"},"owners":[{"id":16171,"kind":"person","name":"ROUSSEAU MICHAEL T","position":1,"cik":"0001233677","reported_name":"ROUSSEAU MICHAEL T","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Director, President and CEO"}}],"security":"Common Stock","published_at":"2017-01-06T13:56:25.000Z","date":"2017-01-04","kind":"disposition_to_issuer","acquired":false,"shares":19618,"ownership":{"direct":false,"nature":"Family Trust"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Pursuant to the terms of the Agreement and Plan of Merger, dated April 27, 2016, by and among Abbott Laboratories (\"Abbott\"), the Issuer, Vault Merger Sub, Inc. and Vault Merger Sub, LLC (the \"Merger Agreement\"), each share of Issuer Common Stock was cancelled in exchange for $46.75 in cash and 0.8708 of a share of Abbott Common Stock (the \"Merger Consideration\"), less any applicable withholding taxes, and provided that cash is payable in respect of any fractional shares of Abbott stock."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F5","text":"The reporting person disclaims beneficial ownership of these securities, and this report shall not be deemed an admission that the reporting person is the beneficial owner of the securities for purposes of Section 16 or for any other purpose."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001179110-17-000618","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/203077/000117911017000618/edgar.xml","form_type":"4"}},{"id":4497404,"issuer":{"id":179857,"kind":"organization","name":"ST JUDE MEDICAL, LLC","symbol":"STJ"},"owners":[{"id":16171,"kind":"person","name":"ROUSSEAU MICHAEL T","position":1,"cik":"0001233677","reported_name":"ROUSSEAU MICHAEL T","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Director, President and CEO"}}],"security":"Common Stock","published_at":"2017-01-06T13:56:25.000Z","date":"2017-01-04","kind":"disposition_to_issuer","acquired":false,"shares":46779,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Pursuant to the terms of the Agreement and Plan of Merger, dated April 27, 2016, by and among Abbott Laboratories (\"Abbott\"), the Issuer, Vault Merger Sub, Inc. and Vault Merger Sub, LLC (the \"Merger Agreement\"), each share of Issuer Common Stock was cancelled in exchange for $46.75 in cash and 0.8708 of a share of Abbott Common Stock (the \"Merger Consideration\"), less any applicable withholding taxes, and provided that cash is payable in respect of any fractional shares of Abbott stock."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001179110-17-000618","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/203077/000117911017000618/edgar.xml","form_type":"4"}},{"id":4516303,"issuer":{"id":179857,"kind":"organization","name":"ST JUDE MEDICAL, LLC","symbol":"STJ"},"owners":[{"id":16171,"kind":"person","name":"ROUSSEAU MICHAEL T","position":1,"cik":"0001233677","reported_name":"ROUSSEAU MICHAEL T","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Restricted Stock Units","published_at":"2016-12-20T17:15:41.000Z","date":"2016-12-17","kind":"exercise","acquired":false,"shares":9263,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of the Company's common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"The restricted stock units will vest 25% on December 17th annually beginning the date shown."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of the Company's common stock."}],"balance_after":27789,"derivative":{"exercise_date":"2016-12-17","underlying":"Common Stock","underlying_shares":37052},"source":{"system":"sec-edgar","filing":"0001179110-16-033313","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":13,"url":"https://www.sec.gov/Archives/edgar/data/203077/000117911016033313/edgar.xml","form_type":"4"}},{"id":4516302,"issuer":{"id":179857,"kind":"organization","name":"ST JUDE MEDICAL, LLC","symbol":"STJ"},"owners":[{"id":16171,"kind":"person","name":"ROUSSEAU MICHAEL T","position":1,"cik":"0001233677","reported_name":"ROUSSEAU MICHAEL T","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Restricted Stock Units","published_at":"2016-12-20T17:15:41.000Z","date":"2016-12-17","kind":"exercise","acquired":false,"shares":4107,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of the Company's common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"The restricted stock units will vest 25% on December 17th annually beginning the date shown."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of the Company's common stock."}],"balance_after":8214,"derivative":{"exercise_date":"2015-12-17","underlying":"Common Stock","underlying_shares":12321},"source":{"system":"sec-edgar","filing":"0001179110-16-033313","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":12,"url":"https://www.sec.gov/Archives/edgar/data/203077/000117911016033313/edgar.xml","form_type":"4"}},{"id":4516301,"issuer":{"id":179857,"kind":"organization","name":"ST JUDE MEDICAL, LLC","symbol":"STJ"},"owners":[{"id":16171,"kind":"person","name":"ROUSSEAU MICHAEL T","position":1,"cik":"0001233677","reported_name":"ROUSSEAU MICHAEL T","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Restricted Stock Units","published_at":"2016-12-20T17:15:41.000Z","date":"2016-12-17","kind":"exercise","acquired":false,"shares":4474,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of the Company's common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"The restricted stock units will vest 25% on December 17th annually beginning the date shown."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of the Company's common stock."}],"balance_after":4474,"derivative":{"exercise_date":"2014-12-17","underlying":"Common Stock","underlying_shares":8948},"source":{"system":"sec-edgar","filing":"0001179110-16-033313","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":11,"url":"https://www.sec.gov/Archives/edgar/data/203077/000117911016033313/edgar.xml","form_type":"4"}},{"id":4516300,"issuer":{"id":179857,"kind":"organization","name":"ST JUDE MEDICAL, LLC","symbol":"STJ"},"owners":[{"id":16171,"kind":"person","name":"ROUSSEAU MICHAEL T","position":1,"cik":"0001233677","reported_name":"ROUSSEAU MICHAEL T","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Restricted Stock Units","published_at":"2016-12-20T17:15:41.000Z","date":"2016-12-17","kind":"exercise","acquired":false,"shares":8000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of the Company's common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"The restricted stock units will vest 25% on December 17th annually beginning the date shown."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of the Company's common stock."}],"balance_after":0,"derivative":{"exercise_date":"2013-12-17","underlying":"Common Stock","underlying_shares":8000},"source":{"system":"sec-edgar","filing":"0001179110-16-033313","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":10,"url":"https://www.sec.gov/Archives/edgar/data/203077/000117911016033313/edgar.xml","form_type":"4"}},{"id":4516299,"issuer":{"id":179857,"kind":"organization","name":"ST JUDE MEDICAL, LLC","symbol":"STJ"},"owners":[{"id":16171,"kind":"person","name":"ROUSSEAU MICHAEL T","position":1,"cik":"0001233677","reported_name":"ROUSSEAU MICHAEL T","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Common Stock","published_at":"2016-12-20T17:15:41.000Z","date":"2016-12-17","kind":"tax_withholding","acquired":false,"shares":3897,"price":79.2,"value":308642.4,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F5","text":"9,263 shares of restricted stock vested on December 17, 2016. 3,897 shares were used to pay taxes and 5,366 shares were released."}],"balance_after":46779,"source":{"system":"sec-edgar","filing":"0001179110-16-033313","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/203077/000117911016033313/edgar.xml","form_type":"4"}},{"id":4516298,"issuer":{"id":179857,"kind":"organization","name":"ST JUDE MEDICAL, LLC","symbol":"STJ"},"owners":[{"id":16171,"kind":"person","name":"ROUSSEAU MICHAEL T","position":1,"cik":"0001233677","reported_name":"ROUSSEAU MICHAEL T","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Common Stock","published_at":"2016-12-20T17:15:41.000Z","date":"2016-12-17","kind":"exercise","acquired":true,"shares":9263,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of the Company's common stock."}],"balance_after":50676,"source":{"system":"sec-edgar","filing":"0001179110-16-033313","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/203077/000117911016033313/edgar.xml","form_type":"4"}},{"id":4516297,"issuer":{"id":179857,"kind":"organization","name":"ST JUDE MEDICAL, LLC","symbol":"STJ"},"owners":[{"id":16171,"kind":"person","name":"ROUSSEAU MICHAEL T","position":1,"cik":"0001233677","reported_name":"ROUSSEAU MICHAEL T","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Common Stock","published_at":"2016-12-20T17:15:41.000Z","date":"2016-12-17","kind":"tax_withholding","acquired":false,"shares":1730,"price":79.2,"value":137016.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F4","text":"4,107 shares of restricted stock vested on December 17, 2016. 1,730 shares were used to pay taxes and 2,377 shares were released."}],"balance_after":41413,"source":{"system":"sec-edgar","filing":"0001179110-16-033313","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/203077/000117911016033313/edgar.xml","form_type":"4"}},{"id":4516296,"issuer":{"id":179857,"kind":"organization","name":"ST JUDE MEDICAL, LLC","symbol":"STJ"},"owners":[{"id":16171,"kind":"person","name":"ROUSSEAU MICHAEL T","position":1,"cik":"0001233677","reported_name":"ROUSSEAU MICHAEL T","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Common Stock","published_at":"2016-12-20T17:15:41.000Z","date":"2016-12-17","kind":"exercise","acquired":true,"shares":4107,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of the Company's common stock."}],"balance_after":43143,"source":{"system":"sec-edgar","filing":"0001179110-16-033313","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/203077/000117911016033313/edgar.xml","form_type":"4"}},{"id":4516295,"issuer":{"id":179857,"kind":"organization","name":"ST JUDE MEDICAL, LLC","symbol":"STJ"},"owners":[{"id":16171,"kind":"person","name":"ROUSSEAU MICHAEL T","position":1,"cik":"0001233677","reported_name":"ROUSSEAU MICHAEL T","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Common Stock","published_at":"2016-12-20T17:15:41.000Z","date":"2016-12-17","kind":"tax_withholding","acquired":false,"shares":1886,"price":79.2,"value":149371.2,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"4,474 shares of restricted stock vested on December 17, 2016. 1,886 shares were used to pay taxes and 2,588 shares were released."}],"balance_after":39036,"source":{"system":"sec-edgar","filing":"0001179110-16-033313","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/203077/000117911016033313/edgar.xml","form_type":"4"}},{"id":4516294,"issuer":{"id":179857,"kind":"organization","name":"ST JUDE MEDICAL, LLC","symbol":"STJ"},"owners":[{"id":16171,"kind":"person","name":"ROUSSEAU MICHAEL T","position":1,"cik":"0001233677","reported_name":"ROUSSEAU MICHAEL T","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Common Stock","published_at":"2016-12-20T17:15:41.000Z","date":"2016-12-17","kind":"exercise","acquired":true,"shares":4474,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of the Company's common stock."}],"balance_after":40922,"source":{"system":"sec-edgar","filing":"0001179110-16-033313","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/203077/000117911016033313/edgar.xml","form_type":"4"}},{"id":4516293,"issuer":{"id":179857,"kind":"organization","name":"ST JUDE MEDICAL, LLC","symbol":"STJ"},"owners":[{"id":16171,"kind":"person","name":"ROUSSEAU MICHAEL T","position":1,"cik":"0001233677","reported_name":"ROUSSEAU MICHAEL T","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Common Stock","published_at":"2016-12-20T17:15:41.000Z","date":"2016-12-17","kind":"tax_withholding","acquired":false,"shares":3374,"price":79.2,"value":267220.8,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"8,000 shares of restricted stock vested on December 17, 2016. 3,374 shares were used to pay taxes and 4,626 shares were released."}],"balance_after":36448,"source":{"system":"sec-edgar","filing":"0001179110-16-033313","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/203077/000117911016033313/edgar.xml","form_type":"4"}},{"id":4516292,"issuer":{"id":179857,"kind":"organization","name":"ST JUDE MEDICAL, LLC","symbol":"STJ"},"owners":[{"id":16171,"kind":"person","name":"ROUSSEAU MICHAEL T","position":1,"cik":"0001233677","reported_name":"ROUSSEAU MICHAEL T","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Common Stock","published_at":"2016-12-20T17:15:41.000Z","date":"2016-12-17","kind":"exercise","acquired":true,"shares":8000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of the Company's common stock."}],"balance_after":39822,"source":{"system":"sec-edgar","filing":"0001179110-16-033313","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/203077/000117911016033313/edgar.xml","form_type":"4"}},{"id":4517956,"issuer":{"id":179857,"kind":"organization","name":"ST JUDE MEDICAL, LLC","symbol":"STJ"},"owners":[{"id":16171,"kind":"person","name":"ROUSSEAU MICHAEL T","position":1,"cik":"0001233677","reported_name":"ROUSSEAU MICHAEL T","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Director, President and CEO"}}],"security":"Stock Options (Right to Buy)","published_at":"2016-12-19T16:10:02.000Z","date":"2016-10-18","kind":"gift","acquired":true,"shares":36148,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"Family Trust"},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"The option shares vest 25% on each of the first four anniversary dates of the date of the grant beginning on the date shown."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F1","text":"The reporting person disclaims beneficial ownership of these securities, and this report shall not be deemed an admission that the reporting person is the beneficial owner of the securities for purposes of Section 16 or for any other purpose."}],"balance_after":36148,"derivative":{"exercise_price":69.08,"exercise_date":"2015-12-17","expiration_date":"2022-12-08","underlying":"Common Stock","underlying_shares":36148},"source":{"system":"sec-edgar","filing":"0001179110-16-033192","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":18,"url":"https://www.sec.gov/Archives/edgar/data/203077/000117911016033192/edgar.xml","form_type":"4"}},{"id":4517955,"issuer":{"id":179857,"kind":"organization","name":"ST JUDE MEDICAL, LLC","symbol":"STJ"},"owners":[{"id":16171,"kind":"person","name":"ROUSSEAU MICHAEL T","position":1,"cik":"0001233677","reported_name":"ROUSSEAU MICHAEL T","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Director, President and CEO"}}],"security":"Stock Options (Right to Buy)","published_at":"2016-12-19T16:10:02.000Z","date":"2016-10-18","kind":"gift","acquired":false,"shares":36148,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"The option shares vest 25% on each of the first four anniversary dates of the date of the grant beginning on the date shown."}],"balance_after":108444,"derivative":{"exercise_price":69.08,"exercise_date":"2015-12-17","expiration_date":"2022-12-08","underlying":"Common Stock","underlying_shares":144592},"source":{"system":"sec-edgar","filing":"0001179110-16-033192","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":17,"url":"https://www.sec.gov/Archives/edgar/data/203077/000117911016033192/edgar.xml","form_type":"4"}},{"id":4517954,"issuer":{"id":179857,"kind":"organization","name":"ST JUDE MEDICAL, LLC","symbol":"STJ"},"owners":[{"id":16171,"kind":"person","name":"ROUSSEAU MICHAEL T","position":1,"cik":"0001233677","reported_name":"ROUSSEAU MICHAEL T","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Director, President and CEO"}}],"security":"Stock Options (Right to Buy)","published_at":"2016-12-19T16:10:02.000Z","date":"2016-10-18","kind":"gift","acquired":true,"shares":74570,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"Family Trust"},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"The option shares vest 25% on each of the first four anniversary dates of the date of the grant beginning on the date shown."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F1","text":"The reporting person disclaims beneficial ownership of these securities, and this report shall not be deemed an admission that the reporting person is the beneficial owner of the securities for purposes of Section 16 or for any other purpose."}],"balance_after":74570,"derivative":{"exercise_price":59.41,"exercise_date":"2014-12-17","expiration_date":"2021-12-10","underlying":"Common Stock","underlying_shares":74570},"source":{"system":"sec-edgar","filing":"0001179110-16-033192","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":16,"url":"https://www.sec.gov/Archives/edgar/data/203077/000117911016033192/edgar.xml","form_type":"4"}},{"id":4517953,"issuer":{"id":179857,"kind":"organization","name":"ST JUDE MEDICAL, LLC","symbol":"STJ"},"owners":[{"id":16171,"kind":"person","name":"ROUSSEAU MICHAEL T","position":1,"cik":"0001233677","reported_name":"ROUSSEAU MICHAEL T","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Director, President and CEO"}}],"security":"Stock Options (Right to Buy)","published_at":"2016-12-19T16:10:02.000Z","date":"2016-10-18","kind":"gift","acquired":false,"shares":74570,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"The option shares vest 25% on each of the first four anniversary dates of the date of the grant beginning on the date shown."}],"balance_after":74570,"derivative":{"exercise_price":59.41,"exercise_date":"2014-12-17","expiration_date":"2021-12-10","underlying":"Common Stock","underlying_shares":149140},"source":{"system":"sec-edgar","filing":"0001179110-16-033192","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":15,"url":"https://www.sec.gov/Archives/edgar/data/203077/000117911016033192/edgar.xml","form_type":"4"}},{"id":4517952,"issuer":{"id":179857,"kind":"organization","name":"ST JUDE MEDICAL, LLC","symbol":"STJ"},"owners":[{"id":16171,"kind":"person","name":"ROUSSEAU MICHAEL T","position":1,"cik":"0001233677","reported_name":"ROUSSEAU MICHAEL T","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Director, President and CEO"}}],"security":"Stock Options (Right to Buy)","published_at":"2016-12-19T16:10:02.000Z","date":"2016-10-18","kind":"gift","acquired":true,"shares":183750,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"Family Trust"},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"The option shares vest 25% on each of the first four anniversary dates of the date of the grant beginning on the date shown."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F1","text":"The reporting person disclaims beneficial ownership of these securities, and this report shall not be deemed an admission that the reporting person is the beneficial owner of the securities for purposes of Section 16 or for any other purpose."}],"balance_after":183750,"derivative":{"exercise_price":35.27,"exercise_date":"2013-12-17","expiration_date":"2020-12-10","underlying":"Common Stock","underlying_shares":183750},"source":{"system":"sec-edgar","filing":"0001179110-16-033192","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":14,"url":"https://www.sec.gov/Archives/edgar/data/203077/000117911016033192/edgar.xml","form_type":"4"}},{"id":4517951,"issuer":{"id":179857,"kind":"organization","name":"ST JUDE MEDICAL, LLC","symbol":"STJ"},"owners":[{"id":16171,"kind":"person","name":"ROUSSEAU MICHAEL T","position":1,"cik":"0001233677","reported_name":"ROUSSEAU MICHAEL T","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Director, President and CEO"}}],"security":"Stock Options (Right to Buy)","published_at":"2016-12-19T16:10:02.000Z","date":"2016-10-18","kind":"gift","acquired":false,"shares":183750,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"The option shares vest 25% on each of the first four anniversary dates of the date of the grant beginning on the date shown."}],"balance_after":61250,"derivative":{"exercise_price":35.27,"exercise_date":"2013-12-17","expiration_date":"2020-12-10","underlying":"Common Stock","underlying_shares":245000},"source":{"system":"sec-edgar","filing":"0001179110-16-033192","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":13,"url":"https://www.sec.gov/Archives/edgar/data/203077/000117911016033192/edgar.xml","form_type":"4"}},{"id":4517950,"issuer":{"id":179857,"kind":"organization","name":"ST JUDE MEDICAL, LLC","symbol":"STJ"},"owners":[{"id":16171,"kind":"person","name":"ROUSSEAU MICHAEL T","position":1,"cik":"0001233677","reported_name":"ROUSSEAU MICHAEL T","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Director, President and CEO"}}],"security":"Stock Options (Right to Buy)","published_at":"2016-12-19T16:10:02.000Z","date":"2016-10-18","kind":"gift","acquired":true,"shares":300000,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"Family Trust"},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Fully vested at the time of filing."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F1","text":"The reporting person disclaims beneficial ownership of these securities, and this report shall not be deemed an admission that the reporting person is the beneficial owner of the securities for purposes of Section 16 or for any other purpose."}],"balance_after":300000,"derivative":{"exercise_price":34.96,"exercise_date":"2012-12-17","expiration_date":"2019-12-12","underlying":"Common Stock","underlying_shares":300000},"source":{"system":"sec-edgar","filing":"0001179110-16-033192","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":12,"url":"https://www.sec.gov/Archives/edgar/data/203077/000117911016033192/edgar.xml","form_type":"4"}},{"id":4517949,"issuer":{"id":179857,"kind":"organization","name":"ST JUDE MEDICAL, LLC","symbol":"STJ"},"owners":[{"id":16171,"kind":"person","name":"ROUSSEAU MICHAEL T","position":1,"cik":"0001233677","reported_name":"ROUSSEAU MICHAEL T","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Director, President and CEO"}}],"security":"Stock Options (Right to Buy)","published_at":"2016-12-19T16:10:02.000Z","date":"2016-10-18","kind":"gift","acquired":false,"shares":300000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Fully vested at the time of filing."}],"balance_after":0,"derivative":{"exercise_price":34.96,"exercise_date":"2012-12-17","expiration_date":"2019-12-12","underlying":"Common Stock","underlying_shares":300000},"source":{"system":"sec-edgar","filing":"0001179110-16-033192","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":11,"url":"https://www.sec.gov/Archives/edgar/data/203077/000117911016033192/edgar.xml","form_type":"4"}},{"id":4517948,"issuer":{"id":179857,"kind":"organization","name":"ST JUDE MEDICAL, LLC","symbol":"STJ"},"owners":[{"id":16171,"kind":"person","name":"ROUSSEAU MICHAEL T","position":1,"cik":"0001233677","reported_name":"ROUSSEAU MICHAEL T","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Director, President and CEO"}}],"security":"Stock Options (Right to Buy)","published_at":"2016-12-19T16:10:02.000Z","date":"2016-10-18","kind":"gift","acquired":true,"shares":204000,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"Family Trust"},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Fully vested at the time of filing."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F1","text":"The reporting person disclaims beneficial ownership of these securities, and this report shall not be deemed an admission that the reporting person is the beneficial owner of the securities for purposes of Section 16 or for any other purpose."}],"balance_after":204000,"derivative":{"exercise_price":41.65,"exercise_date":"2011-12-14","expiration_date":"2017-12-14","underlying":"Common Stock","underlying_shares":204000},"source":{"system":"sec-edgar","filing":"0001179110-16-033192","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":10,"url":"https://www.sec.gov/Archives/edgar/data/203077/000117911016033192/edgar.xml","form_type":"4"}},{"id":4517947,"issuer":{"id":179857,"kind":"organization","name":"ST JUDE MEDICAL, LLC","symbol":"STJ"},"owners":[{"id":16171,"kind":"person","name":"ROUSSEAU MICHAEL T","position":1,"cik":"0001233677","reported_name":"ROUSSEAU MICHAEL T","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Director, President and CEO"}}],"security":"Stock Options (Right to Buy)","published_at":"2016-12-19T16:10:02.000Z","date":"2016-10-18","kind":"gift","acquired":false,"shares":204000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Fully vested at the time of filing."}],"balance_after":0,"derivative":{"exercise_price":41.65,"exercise_date":"2011-12-14","expiration_date":"2018-12-14","underlying":"Common Stock","underlying_shares":204000},"source":{"system":"sec-edgar","filing":"0001179110-16-033192","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/203077/000117911016033192/edgar.xml","form_type":"4"}},{"id":4517946,"issuer":{"id":179857,"kind":"organization","name":"ST JUDE MEDICAL, LLC","symbol":"STJ"},"owners":[{"id":16171,"kind":"person","name":"ROUSSEAU MICHAEL T","position":1,"cik":"0001233677","reported_name":"ROUSSEAU MICHAEL T","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Director, President and CEO"}}],"security":"Stock Options (Right to Buy)","published_at":"2016-12-19T16:10:02.000Z","date":"2016-10-18","kind":"gift","acquired":true,"shares":182000,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"Family Trust"},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Fully vested at the time of filing."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F1","text":"The reporting person disclaims beneficial ownership of these securities, and this report shall not be deemed an admission that the reporting person is the beneficial owner of the securities for purposes of Section 16 or for any other purpose."}],"balance_after":182000,"derivative":{"exercise_price":30.59,"exercise_date":"2010-12-14","expiration_date":"2017-12-14","underlying":"Common Stock","underlying_shares":182000},"source":{"system":"sec-edgar","filing":"0001179110-16-033192","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/203077/000117911016033192/edgar.xml","form_type":"4"}},{"id":4517945,"issuer":{"id":179857,"kind":"organization","name":"ST JUDE MEDICAL, LLC","symbol":"STJ"},"owners":[{"id":16171,"kind":"person","name":"ROUSSEAU MICHAEL T","position":1,"cik":"0001233677","reported_name":"ROUSSEAU MICHAEL T","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Director, President and CEO"}}],"security":"Stock Options (Right to Buy)","published_at":"2016-12-19T16:10:02.000Z","date":"2016-10-18","kind":"gift","acquired":false,"shares":182000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Fully vested at the time of filing."}],"balance_after":0,"derivative":{"exercise_price":30.59,"exercise_date":"2010-12-14","expiration_date":"2017-12-14","underlying":"Common Stock","underlying_shares":182000},"source":{"system":"sec-edgar","filing":"0001179110-16-033192","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/203077/000117911016033192/edgar.xml","form_type":"4"}},{"id":4517944,"issuer":{"id":179857,"kind":"organization","name":"ST JUDE MEDICAL, LLC","symbol":"STJ"},"owners":[{"id":16171,"kind":"person","name":"ROUSSEAU MICHAEL T","position":1,"cik":"0001233677","reported_name":"ROUSSEAU MICHAEL T","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Director, President and CEO"}}],"security":"Stock Options (Right to Buy)","published_at":"2016-12-19T16:10:02.000Z","date":"2016-12-15","kind":"exercise","acquired":false,"shares":50000,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"Family Trust"},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Fully vested at the time of filing."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F1","text":"The reporting person disclaims beneficial ownership of these securities, and this report shall not be deemed an admission that the reporting person is the beneficial owner of the securities for purposes of Section 16 or for any other purpose."}],"balance_after":0,"derivative":{"exercise_price":30.58,"exercise_date":"2009-12-15","expiration_date":"2016-12-15","underlying":"Common Stock","underlying_shares":50000},"source":{"system":"sec-edgar","filing":"0001179110-16-033192","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/203077/000117911016033192/edgar.xml","form_type":"4"}},{"id":4517943,"issuer":{"id":179857,"kind":"organization","name":"ST JUDE MEDICAL, LLC","symbol":"STJ"},"owners":[{"id":16171,"kind":"person","name":"ROUSSEAU MICHAEL T","position":1,"cik":"0001233677","reported_name":"ROUSSEAU MICHAEL T","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Director, President and CEO"}}],"security":"Stock Options (Right to Buy)","published_at":"2016-12-19T16:10:02.000Z","date":"2016-10-18","kind":"gift","acquired":true,"shares":50000,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"Family Trust"},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Fully vested at the time of filing."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F1","text":"The reporting person disclaims beneficial ownership of these securities, and this report shall not be deemed an admission that the reporting person is the beneficial owner of the securities for purposes of Section 16 or for any other purpose."}],"balance_after":50000,"derivative":{"exercise_price":30.58,"exercise_date":"2009-12-15","expiration_date":"2016-12-15","underlying":"Common Stock","underlying_shares":50000},"source":{"system":"sec-edgar","filing":"0001179110-16-033192","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/203077/000117911016033192/edgar.xml","form_type":"4"}},{"id":4517942,"issuer":{"id":179857,"kind":"organization","name":"ST JUDE MEDICAL, LLC","symbol":"STJ"},"owners":[{"id":16171,"kind":"person","name":"ROUSSEAU MICHAEL T","position":1,"cik":"0001233677","reported_name":"ROUSSEAU MICHAEL T","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Director, President and CEO"}}],"security":"Stock Options (Right to Buy)","published_at":"2016-12-19T16:10:02.000Z","date":"2016-10-18","kind":"gift","acquired":false,"shares":50000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Fully vested at the time of filing."}],"balance_after":0,"derivative":{"exercise_price":30.58,"exercise_date":"2009-12-15","expiration_date":"2016-12-15","underlying":"Common Stock","underlying_shares":50000},"source":{"system":"sec-edgar","filing":"0001179110-16-033192","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/203077/000117911016033192/edgar.xml","form_type":"4"}},{"id":4517941,"issuer":{"id":179857,"kind":"organization","name":"ST JUDE MEDICAL, LLC","symbol":"STJ"},"owners":[{"id":16171,"kind":"person","name":"ROUSSEAU MICHAEL T","position":1,"cik":"0001233677","reported_name":"ROUSSEAU MICHAEL T","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Director, President and CEO"}}],"security":"Common Stock","published_at":"2016-12-19T16:10:02.000Z","date":"2012-12-15","kind":"tax_withholding","acquired":false,"shares":30382,"price":79.88,"value":2426914.16,"ownership":{"direct":false,"nature":"Family Trust"},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Shares of common stock withheld to pay the exercise price of the stock options and to pay tax withholdings. The 50,000 shares acquired upon the option exercise, net of 30,382 shares used to pay exercise price and taxes, resulted in 19,618 shares that were retained."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F1","text":"The reporting person disclaims beneficial ownership of these securities, and this report shall not be deemed an admission that the reporting person is the beneficial owner of the securities for purposes of Section 16 or for any other purpose."}],"balance_after":19618,"source":{"system":"sec-edgar","filing":"0001179110-16-033192","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/203077/000117911016033192/edgar.xml","form_type":"4"}},{"id":4517940,"issuer":{"id":179857,"kind":"organization","name":"ST JUDE MEDICAL, LLC","symbol":"STJ"},"owners":[{"id":16171,"kind":"person","name":"ROUSSEAU MICHAEL T","position":1,"cik":"0001233677","reported_name":"ROUSSEAU MICHAEL T","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Director, President and CEO"}}],"security":"Common Stock","published_at":"2016-12-19T16:10:02.000Z","date":"2012-12-15","kind":"exercise","acquired":true,"shares":50000,"price":30.58,"value":1529000.0,"ownership":{"direct":false,"nature":"Family Trust"},"footnotes":[{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F1","text":"The reporting person disclaims beneficial ownership of these securities, and this report shall not be deemed an admission that the reporting person is the beneficial owner of the securities for purposes of Section 16 or for any other purpose."}],"balance_after":50000,"source":{"system":"sec-edgar","filing":"0001179110-16-033192","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/203077/000117911016033192/edgar.xml","form_type":"4"}}]}